Point72 Asset Management
CRNX icon

Point72 Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$57.5M Buy
1,998,161
+1,219,763
+157% +$35.1M 0.11% 201
2025
Q1
$26.1M Sell
778,398
-2,010,541
-72% -$67.4M 0.06% 330
2024
Q4
$143M Buy
2,788,939
+488,296
+21% +$25M 0.31% 58
2024
Q3
$118M Sell
2,300,643
-480,213
-17% -$24.5M 0.3% 60
2024
Q2
$125M Sell
2,780,856
-2,168,630
-44% -$97.1M 0.33% 65
2024
Q1
$232M Buy
4,949,486
+1,532,586
+45% +$71.7M 0.56% 21
2023
Q4
$122M Sell
3,416,900
-808,400
-19% -$28.8M 0.29% 60
2023
Q3
$126M Buy
+4,225,300
New +$126M 0.37% 44
2023
Q2
Sell
-226,400
Closed -$3.64M 1706
2023
Q1
$3.64M Sell
226,400
-1,134,600
-83% -$18.2M 0.01% 723
2022
Q4
$24.9M Buy
1,361,000
+50,800
+4% +$930K 0.08% 271
2022
Q3
$25.7M Sell
1,310,200
-22,600
-2% -$444K 0.1% 252
2022
Q2
$24.9M Buy
1,332,800
+126,462
+10% +$2.36M 0.1% 249
2022
Q1
$26.5M Buy
1,206,338
+101,862
+9% +$2.24M 0.11% 235
2021
Q4
$31.4M Buy
1,104,476
+654,676
+146% +$18.6M 0.13% 222
2021
Q3
$9.47M Sell
449,800
-258,333
-36% -$5.44M 0.04% 472
2021
Q2
$13.3M Sell
708,133
-566,867
-44% -$10.7M 0.06% 361
2021
Q1
$19.5M Buy
1,275,000
+49,997
+4% +$764K 0.09% 262
2020
Q4
$17.3M Buy
1,225,003
+713,015
+139% +$10.1M 0.08% 294
2020
Q3
$8.02M Buy
511,988
+117,156
+30% +$1.84M 0.04% 427
2020
Q2
$6.92M Buy
+394,832
New +$6.92M 0.05% 396
2020
Q1
Sell
-33,865
Closed -$850K 785
2019
Q4
$850K Sell
33,865
-98,135
-74% -$2.46M ﹤0.01% 693
2019
Q3
$1.99M Buy
+132,000
New +$1.99M 0.01% 540